Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

A103 immunostaining in the diagnosis of adrenal cortical tumors: an immunohistochemical study of 316 cases.

Loy TS, Phillips RW, Linder CL.

Arch Pathol Lab Med. 2002 Feb;126(2):170-2.

PMID:
11825112
[PubMed - indexed for MEDLINE]
2.

Diagnostic utility of the monoclonal antibody A103 in fine-needle aspiration biopsies of the adrenal.

Shin SJ, Hoda RS, Ying L, DeLellis RA.

Am J Clin Pathol. 2000 Feb;113(2):295-302.

PMID:
10664633
[PubMed - indexed for MEDLINE]
Free Article
3.

A comparison of A103 and inhibin reactivity in adrenal cortical tumors: distinction from hepatocellular carcinoma and renal tumors.

Renshaw AA, Granter SR.

Mod Pathol. 1998 Dec;11(12):1160-4.

PMID:
9872645
[PubMed - indexed for MEDLINE]
4.

Melan A (A103) is expressed in adrenocortical neoplasms but not in renal cell and hepatocellular carcinomas.

Ghorab Z, Jorda M, Ganjei P, Nadji M.

Appl Immunohistochem Mol Morphol. 2003 Dec;11(4):330-3.

PMID:
14663359
[PubMed - indexed for MEDLINE]
5.

Melan-A (A103) and inhibin expression in ovarian neoplasms.

Yao DX, Soslow RA, Hedvat CV, Leitao M, Baergen RN.

Appl Immunohistochem Mol Morphol. 2003 Sep;11(3):244-9.

PMID:
12966351
[PubMed - indexed for MEDLINE]
6.

Immunoreactivity for A103, an antibody to melan-A (Mart-1), in adrenocortical and other steroid tumors.

Busam KJ, Iversen K, Coplan KA, Old LJ, Stockert E, Chen YT, McGregor D, Jungbluth A.

Am J Surg Pathol. 1998 Jan;22(1):57-63.

PMID:
9422316
[PubMed - indexed for MEDLINE]
7.

A103: An anti-melan-a monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues.

Jungbluth AA, Busam KJ, Gerald WL, Stockert E, Coplan KA, Iversen K, MacGregor DP, Old LJ, Chen YT.

Am J Surg Pathol. 1998 May;22(5):595-602.

PMID:
9591730
[PubMed - indexed for MEDLINE]
8.

Melan-A, a new melanocytic differentiation marker.

Busam KJ, Jungbluth AA.

Adv Anat Pathol. 1999 Jan;6(1):12-8. Review.

PMID:
10197235
[PubMed - indexed for MEDLINE]
9.

Melan A/MART-1 immunoreactivity in formalin-fixed paraffin-embedded primary and metastatic melanoma: frequency and distribution.

Hofbauer GF, Kamarashev J, Geertsen R, Böni R, Dummer R.

Melanoma Res. 1998 Aug;8(4):337-43.

PMID:
9764809
[PubMed - indexed for MEDLINE]
10.

[Diagnostic value of A103 and inhibin-alpha in adrenocortical tumors: an immunohistochemical study using tissue microarray techniques].

Zhang HY, Wang XJ, Liu WP, Jiang LL, Li GD, Guo J, Zhang YH.

Zhonghua Bing Li Xue Za Zhi. 2004 Jun;33(3):203-7. Chinese.

PMID:
15256108
[PubMed - indexed for MEDLINE]
11.

Comparison of immunohistochemical markers in the differential diagnosis of adrenocortical tumors: immunohistochemical analysis of adrenocortical tumors.

Zhang H, Bu H, Chen H, Wei B, Liu W, Guo J, Li F, Liao D, Tang Y, Zhang Z.

Appl Immunohistochem Mol Morphol. 2008 Jan;16(1):32-9.

PMID:
18091323
[PubMed - indexed for MEDLINE]
12.

Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma.

Busam KJ, Chen YT, Old LJ, Stockert E, Iversen K, Coplan KA, Rosai J, Barnhill RL, Jungbluth AA.

Am J Surg Pathol. 1998 Aug;22(8):976-82.

PMID:
9706977
[PubMed - indexed for MEDLINE]
13.

The role of calretinin, inhibin, melan-A, BCL-2, and C-kit in differentiating adrenal cortical and medullary tumors: an immunohistochemical study.

Zhang PJ, Genega EM, Tomaszewski JE, Pasha TL, LiVolsi VA.

Mod Pathol. 2003 Jun;16(6):591-7.

PMID:
12808065
[PubMed - indexed for MEDLINE]
Free Article
14.

Immunoreactivity of A103, an antibody to Melan A, in canine steroid-producing tissues and their tumors.

Ramos-Vara JA, Beissenherz ME, Miller MA, Johnson GC, Kreeger JM, Pace LW, Turk JR, Turnquist SE, Watson GL, Yamini B.

J Vet Diagn Invest. 2001 Jul;13(4):328-32.

PMID:
11478605
[PubMed - indexed for MEDLINE]
Free Article
15.

Immunohistochemical staining of normal, hyperplastic, and neoplastic adrenal cortex with a monoclonal antibody against alpha inhibin.

McCluggage WG, Burton J, Maxwell P, Sloan JM.

J Clin Pathol. 1998 Feb;51(2):114-6.

PMID:
9602683
[PubMed - indexed for MEDLINE]
Free PMC Article
17.
18.

Expression of Melan-A/MART-1 antigen as a prognostic factor in primary cutaneous melanoma.

Berset M, Cerottini JP, Guggisberg D, Romero P, Burri F, Rimoldi D, Panizzon RG.

Int J Cancer. 2001 Jan 20;95(1):73-7.

PMID:
11241315
[PubMed - indexed for MEDLINE]
19.

Expression of melanocyte-associated markers gp-100 and Melan-A/MART-1 in angiomyolipomas. An immunohistochemical and rt-PCR analysis.

Jungbluth AA, Iversen K, Coplan K, Williamson B, Chen YT, Stockert E, Old LJ, Busam KJ.

Virchows Arch. 1999 May;434(5):429-35.

PMID:
10389626
[PubMed - indexed for MEDLINE]
20.

Production of recombinant MART-1 proteins and specific antiMART-1 polyclonal and monoclonal antibodies: use in the characterization of the human melanoma antigen MART-1.

Kawakami Y, Battles JK, Kobayashi T, Ennis W, Wang X, Tupesis JP, Marincola FM, Robbins PF, Hearing VJ, Gonda MA, Rosenberg SA.

J Immunol Methods. 1997 Mar 10;202(1):13-25.

PMID:
9075767
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk